1 Min Read
March 8 (Reuters) - Imprimis Pharmaceuticals Inc:
* IMPRIMIS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER 2017 RESULTS
* Q4 REVENUE ROSE 27 PERCENT TO $7.3 MILLION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.